O
OBIO icon

OrbiMed’s Orchestra BioMed OBIO Stock Holding History

OrbiMed’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500,000
Closed -$5.04M – 161
2021
Q4 		$5.04M Hold
500,000
– – 0.06% 135
2021
Q3 		$4.95M Hold
500,000
– – 0.05% 153
2021
Q2 		$5.1M Hold
500,000
– – 0.05% 147
2021
Q1 		$5.59M Hold
500,000
– – 0.05% 138
2020
Q4 		$6.41M Hold
500,000
– – 0.06% 136
2020
Q3 		$5.5M Buy
+500,000
New +$5.61M 0.07% 124

Other funds holding OBIO

DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AC
Amitell Capital Singapore $62.4M AUM 75.98% 1-Year Est. Return
SC
Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return